| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |